Josep Lluis Llorens
Net Worth
Last updated:
What is Josep Lluis Llorens net worth?
The estimated net worth of Mr. Josep Lluis Llorens is at least $6,004,739 as of 16 May 2024. He owns shares worth $917,672 as insider, has earned $882,567 from insider trading and has received compensation worth at least $4,204,500 in Haemonetics Corporation.
What is the salary of Josep Lluis Llorens?
Mr. Josep Lluis Llorens salary is $700,750 per year as Senior Vice President of Global Manufacturing & Supply Chain in Haemonetics Corporation.
How old is Josep Lluis Llorens?
Mr. Josep Lluis Llorens is 63 years old, born in 1962.
What stocks does Josep Lluis Llorens currently own?
As insider, Mr. Josep Lluis Llorens owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Haemonetics Corporation (HAE) | Senior Vice President of Global Manufacturing & Supply Chain | 17,172 | $53.44 | $917,672 |
What does Haemonetics Corporation do?
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system. It also provides automated blood component and manual whole blood collection systems, such as MCS brand apheresis equipment to collect specific blood components from the donor; disposable whole blood collection and component storage sets; SafeTrace Tx blood bank information system; and BloodTrack blood management software, a suite of blood management and bedside transfusion solutions that combines software with hardware components, as well as an extension of the hospital's blood bank information system. In addition, the company offers hospital products comprising TEG, ClotPro, and HAS hemostasis analyzer systems that provide a comprehensive assessment of a patient's overall hemostasis; TEG Manager software, which connects various TEG analyzers throughout the hospital, providing clinicians remote access to active and historical test results that inform treatment decisions; and Cell Saver Elite +, an autologous blood recovery system for cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological surgeries. It markets and sells its products through direct sales force, independent distributors, and sales representatives. Haemonetics Corporation was founded in 1971 and is headquartered in Boston, Massachusetts.
Josep Lluis Llorens insider trading
Haemonetics Corporation
Mr. Josep Lluis Llorens has made 12 insider trades between 2019-2024, according to the Form 4 filled with the SEC. Most recently he sold 770 units of HAE stock worth $74,028 on 16 May 2024.
The largest trade he's ever made was exercising 4,928 units of HAE stock on 18 Jul 2023. As of 16 May 2024 he still owns at least 17,172 units of HAE stock.
Haemonetics key executives
Haemonetics Corporation executives and other stock owners filed with the SEC:
- Mr. Christopher A. Simon (61) Chief Executive Officer, Pres & Director
- Mr. Josep Lluis Llorens (63) Senior Vice President of Global Manufacturing & Supply Chain
- Mr. William P. Burke (57) Chief Financial Officer & Executive Vice President
- Ms. Anila Lingamneni (58) Executive Vice President & Chief Technology Officer
- Ms. Michelle L. Basil (53) Executive Vice President, Gen. Counsel & Sec.